Characteristics of Turkish colorectal cancer patients and bevacizumab preference.


Cicin I., Gumus M., Uncu D., Ozkan M., Kilickap S., Elkiran T. E. , ...Daha Fazla

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35 identifier